Menu
DehydraTECH is a revolutionary, patented biodelivery technology that is scientifically proven to consistently and rapidly deliver precise doses of bioactive substances like cannabinoids into the bloodstream, for unparalleled absorption, bioavailability and onset time.
DehydraTECH-THC makes it easy for leading, progressive cannabis edible manufacturers to deliver consistent, premium consumer experiences with the most reliable taste and impact.
Where craft quality meets bioscience – Hill Avenue Cannabis is the DehydraTECH-THC technology licensing, product development and commercialization partner to progressive cannabis brands worldwide who are committed to bringing exceptional, best-in-class cannabis products to market.
DehydraTECH technology was first developed in 2014 by Lexaria Bioscience Corp., a global innovator in drug delivery platforms.
Today, the DehydraTECH intellectual property portfolio consists of 30 granted patents and approximately 50 patents pending worldwide.
Learn more about DehydraTECH and the wide range of applications and research being done by its creator, Lexaria, here:
Interested in learning more about DehydraTECH-THC or working with Hill Avenue Cannabis?